The Food and Drug Administration just announced that it will immediately start using AI across all of its centers, after completing a new generative AI pilot for scientific reviewers.
Supposedly, the AI tool will speed up the FDA’s drug review process by reducing the time its scientists have to spend doing tedious, repetitive tasks — though, given AI’s track record of constantly hallucinating, these claims warrant plenty of scrutiny.
“This is a game-changer technology that has enabled me to…
Article Source
https://futurism.com/fda-ai-approve-drugs
